Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human interleukin-11 derivative vs interleukin-11 for chemotherapy-induced thrombocytopenia
CTR20131909Phase 4Active
- Sponsor
- Shandong Ahua Biological Pharmaceutical
- Start
- Mar 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human interleukin-11 derivative in chemotherapy-induced thrombocytopenia (CIT), sponsored by Shandong Ahua Biological Pharmaceutical. Started Mar 2014; status: active.
02
Drugs
recombinant human interleukin-11 derivative
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on CTR20131909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131909.